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that additional NO is beneficial only at 
certain phases in the wound healing 
cascade, and different wounds may 
require different NO donors. Infected 
wounds would be an obvious target for 
nanoparticle NO (Martinez et al., 2009), 
whereas other NO donors have exhibit-
ed efficacy at healing wounds in diabetic 
mice. Somewhat counterintuitively, the 
relatively large number of NO donors 
shown to improve wound healing seems 
to have slowed the clinical development 
of this family of drugs. The ubiquity and 
simplicity of NO have produced a com-
plex intellectual property environment 
in which the pharmaceutical industry, 
the government, and charitable donors 
are unwilling to fund clinical trials lest 
they lose the commercial benefits result-
ing from a successful outcome to a pat-
ent holder with a competing claim. One 
hopes that such concerns will not hinder 
the clinical development of this promis-
ing line of therapies.
CONFLICT OF INTEREST
Richard B. Weller has advised a number of 
companies on the development of NO donors for 
clinical applications.
RefeRences
Fang FC (2004) Antimicrobial reactive oxygen 
and nitrogen species: concepts and 
controversies. Nat Rev Micro 2:820–32
Friedman AJ, Han G, Navati MS, Chacko M, 
Gunther L, Alfieri A et al. (2008) Sustained 
release nitric oxide releasing nanoparticles: 
characterization of a novel delivery platform 
based on nitrite containing hydrogel/glass 
composites. Nitric Oxide 19:12–20
Hardwick JB, Tucker AT, Wilks M, Johnston A, 
Benjamin N (2001) A novel method for the 
delivery of nitric oxide therapy to the skin 
of human subjects using a semi-permeable 
membrane. Clin Sci (Lond) 100:395–400
Khan F, Pearson RJ, Newton DJ, Belch JJ, Butler AR 
(2003) Chemical synthesis and microvascular 
effects of new nitric oxide donors in humans. 
Clin Sci (Lond) 105:577–84
Lopez-Jaramillo P, Ruano C, Rivera J, Teran E, 
Salazar-Irigoyen R, Esplugues JV et al. (1998) 
Treatment of cutaneous leishmaniasis with 
nitric-oxide donor. Lancet 351:1176–7
Luo JD, Chen AF (2005) Nitric oxide: a newly 
discovered function on wound healing. Acta 
Pharmacol Sin 26:259–64
Martinez LR, Han G, Chacko M, Mihu MR, 
Jacobson M, Gialanella P et al. (2009) 
Antimicrobial and healing efficacy of 
sustained release nitric oxide nanoparticles 
against Staphylococcus aureus skin infection. 
J Invest Dermatol 129:2463–9
Mowbray M, Tan X, Wheatley PS, Morris RE, 
Weller RB (2008) Topically applied nitric 
oxide induces T-lymphocyte infiltration in 
human skin, but minimal inflammation. 
J Invest Dermatol 128:352–60
Weller R, Finnen MJ (2006) The effects of topical 
treatment with acidified nitrite on wound 
healing in normal and diabetic mice. Nitric 
Oxide 15:395–9
Weller R, Price RJ, Ormerod AD, Benjamin N, Leifert 
C (2001) Antimicrobial effect of acidified nitrite 
on dermatophyte fungi, Candida and bacterial 
skin pathogens. J Appl Microbiol 90:648–52
Yamasaki K, Edington HD, McClosky C, Tzeng E, 
Lizonova A, Kovesdi I et al. (1998) Reversal of 
impaired wound repair in iNOS-deficient mice 
by topical adenoviral-mediated iNOS gene 
transfer. J Clin Invest 101:967–71
See related article on pg 2515
spitting Image:  
Tick saliva Assists the causative Agent 
of Lyme Disease in evading  
Host skin’s Innate Immune Response
Joppe W.R. Hovius1
Lyme disease is caused by the spirochete Borrelia burgdorferi and is transmit-
ted through ticks. Inhibition of host skin’s innate immune response might be 
instrumental to both tick feeding and B. burgdorferi transmission. The article 
by Marchal et al. describes how tick saliva suppresses B. burgdorferi–induced 
antimicrobial peptide production. This inhibition directly facilitates survival of 
the spirochete and might lead to diminished chemotaxis of leukocytes toward 
the site of the tick bite.
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Lyme disease, or Lyme borreliosis, was 
first recognized as a distinct clinical enti-
ty in 1975 in Old Lyme, Connecticut, 
in children at the Yale–New Haven 
Hospital who were initially thought 
to have juvenile rheumatoid arthritis 
(Steere et al., 1977). Previously, how-
ever, certain clinical signs of the disease 
had been described in Europe (Afzelius, 
1921). Ixodes scapularis, Ixodes ricinus, 
and Ixodes persulcatus are the most 
important vectors for Lyme borreliosis 
in the United States, Europe, and Asia, 
respectively, and the disease is caused 
by spirochetes of the Borrelia burgdor-
feri sensu lato group (Wang et al., 1999). 
In Europe and Asia, three major Borrelia 
genospecies (B. burgdorferi sensu stric-
to, Borrelia garinii, and Borrelia afzelii) 
are the causative agents. By contrast, 
only B. burgdorferi sensu stricto strains 
are present in the United States. The 
obligate enzootic life cycle of the spi-
rochetes involves ticks, primarily Ixodes 
ticks, and a variety of vertebrate hosts, 
including small rodents, large mammals, 
and birds (Anderson and Magnarelli, 
1980). In general, uninfected tick lar-
vae acquire the bacterium by feeding on 
infected animals. Ticks remain infected 
during their consecutive molting peri-
ods, enabling both nymphal and adult 
ticks to transmit spirochetes to (larger) 
animals and humans.
To secure attachment of the tick 
and to ensure susceptibility of reser-
voir hosts for future tick infestations, 
tick saliva contains modulators of host 
immune responses. During the course 
of a blood meal, which can take up to 
seven days, ticks introduce saliva con-
taining a wide range of physiologically 
active components. Immunosuppressive 
proteins in tick saliva interfere with 
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the host’s innate and adaptive immune 
responses (Figure 1), including inhi-
bition of the complement cascade 
(Ribeiro, 1987); binding of histamine 
(Mans, 2005); impairment of natural kill-
er cell (Kopecky and Kuthejlova, 1998), 
dendritic cell (Hovius et al., 2008a), 
and neutrophil function (Montgomery 
et al., 2004); reduction in antibody titers 
(Wikel and Bergman, 1997); repression 
of production of cytokines such as inter-
leukin (IL)-2, interferon-γ (Anguita et al., 
2002; Gillespie et al., 2001; Kotsyfakis 
et al., 2006), IL-4 (Muller-Doblies et 
al., 2007), and IL-10 (Hannier et al., 
2003); blocking of chemokine activ-
ity (Deruaz et al., 2008); and inhibi-
tion of T-lymphocyte proliferation 
(Ramachandra and Wikel, 1992). In 
recent years, many tick proteins with 
specific functions have been identified 
(reviewed by Hovius et al., 2008b). 
Importantly, immunosuppression by tick 
saliva may result in more efficient trans-
mission of several tick-borne pathogens 
(Wikel, 1999).
For both the tick and the spirochete, 
it is of paramount importance to inhibit 
the host innate immune response, the 
first line of host defense. A crucial part 
of the innate immune response against 
invading microorganisms is the comple-
ment cascade. Many bacteria, such as 
Streptococcus pneumoniae (Neeleman 
et al., 1999) and Neisseria meningitidis 
(Ram et al., 1999), have evolved mecha-
nisms to inhibit complement-mediated 
killing. B. burgdorferi utilizes comple-
ment regulating–acquiring surface pro-
teins (Kraiczy et al., 2001) and Osp E/F 
related proteins (Alitalo et al., 2002; 
Hellwage et al., 2001) to bind factor H 
or FHL protein and consequently inhibit 
complement-mediated borreliacidal act-
ivity. In addition, several tick salivary 
proteins have been identified that inhibit 
different pathways within the comple-
ment cascade (Schroeder et al., 2007; 
Schuijt et al., 2008; Tyson et al., 2008; 
Valenzuela et al., 2000).
Innate immune responses also include 
the family of antimicrobial peptides, an 
ancient form of host defense found in 
both plants and animals that possesses 
bactericidal capacities. Production of 
antimicrobial peptides at the site of 
infection—for instance, the skin—also 
results in chemo taxis of leukocytes. 
Marchal et al. (this issue, 2009) and 
others demonstrate that B. burgdorferi 
is able to induce the production of sev-
eral antimicrobial peptides, including 
human β-defensin-2 and cathelicidin 
LL-37, in human resident skin cells 
(fibroblasts and keratinocytes). In addi-
tion, they show that a selection of these 
antimicrobial peptides exhibit transient 
growth-inhibiting properties against B. 
burgdorferi. Induction of antimicrobial 
peptides could favor a robust innate 
immune response at the site of the tick 
bite, which could not only result in 
clearance of B. burgdorferi but also ham-
per tick feeding. Interestingly, Marchal 
and collaborators now demonstrate that 
salivary gland extract from Ixodes ricinus 
has the capacity to inhibit B. burgdorferi–
induced antimicrobial peptide produc-
tion. This would favor B. burgdorferi 
survival and facilitate infection as well 
as inhibit chemotaxis of leukocytes to 
the site of the tick bite, thereby making 
the tick–host–pathogen interface a less 
hostile environment and favoring tick 
attachment to the host.
Identification of novel functions of 
tick saliva and tick salivary gland extract 
contributes to the understanding of the 
pathogenesis of Lyme disease. This may 
help researchers identify tick saliva pro-
teins that could serve as templates for 
new pharmacological compounds and 
could reveal new ways to prevent or 
treat tick-borne infections such as Lyme 
disease and other emerging tick-borne 
infections.
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Figure 1. Inhibition of skin innate immune responses by tick saliva. During feeding, the tick 
introduces saliva into the host skin. Tick saliva contains numerous proteins with specific functions. The 
figure depicts those with immunosuppressive activity affecting host innate immunity. Several specific 
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